Sander Wuyts, PhD 🧬
@swuyts.bsky.social
Helping scientists find the epitope specificity of their T-cell receptors at @immunewatch.bsky.social (www.immunewatch.com)
Scientist on an entrepreneurial journey
PhD in bioinformatics and microbiology
Ex-Bork (EMBL) and Lebeer lab
Scientist on an entrepreneurial journey
PhD in bioinformatics and microbiology
Ex-Bork (EMBL) and Lebeer lab
Pinned
Why did I trade academia for a startup environment?
Because several scientist I worked with during my PhD convinced me of their mission:
They want to fully decode the T-cell repertoire.
I recently found an old slide that visualises this goal beautifully.
#ImmunoSky
1/5
Because several scientist I worked with during my PhD convinced me of their mission:
They want to fully decode the T-cell repertoire.
I recently found an old slide that visualises this goal beautifully.
#ImmunoSky
1/5
I'll be in London at the festival of Genomics later this week.
Hit me up if you want to connect!
Hit me up if you want to connect!
January 25, 2026 at 7:36 AM
I'll be in London at the festival of Genomics later this week.
Hit me up if you want to connect!
Hit me up if you want to connect!
One of my favourite pics of Peer.
Took this one on a summer day in 2021 during a lab get-to-together at his place.
Cheer to you too Peer.
#PeerBork
Took this one on a summer day in 2021 during a lab get-to-together at his place.
Cheer to you too Peer.
#PeerBork
January 19, 2026 at 9:09 AM
One of my favourite pics of Peer.
Took this one on a summer day in 2021 during a lab get-to-together at his place.
Cheer to you too Peer.
#PeerBork
Took this one on a summer day in 2021 during a lab get-to-together at his place.
Cheer to you too Peer.
#PeerBork
Reposted by Sander Wuyts, PhD 🧬
For many years, Peer Bork organised Bio-IT retreats to bring together the bioinformaticians across EMBL, in Garmisch-Partenkirchen and later Feldberg. Days out on the mountain followed by forward-looking and meta-science oriented sessions in the hut that fueled many projects and careers.
January 17, 2026 at 10:22 AM
For many years, Peer Bork organised Bio-IT retreats to bring together the bioinformaticians across EMBL, in Garmisch-Partenkirchen and later Feldberg. Days out on the mountain followed by forward-looking and meta-science oriented sessions in the hut that fueled many projects and careers.
I can not believe this news.
The EMBL community, microbiome field and bioinformatics in general loses a legend 😢
www.embl.org/news/embl-an...
The EMBL community, microbiome field and bioinformatics in general loses a legend 😢
www.embl.org/news/embl-an...
In remembrance of Peer Bork | EMBL
EMBL and its community are deeply saddened by the death of Peer Bork, the organisation’s Interim Director General.
www.embl.org
January 16, 2026 at 5:10 PM
I can not believe this news.
The EMBL community, microbiome field and bioinformatics in general loses a legend 😢
www.embl.org/news/embl-an...
The EMBL community, microbiome field and bioinformatics in general loses a legend 😢
www.embl.org/news/embl-an...
I'll bee in London at the end of the month for the Festival of Genomics.
Who can I run into?
Who can I run into?
January 12, 2026 at 2:27 PM
I'll bee in London at the end of the month for the Festival of Genomics.
Who can I run into?
Who can I run into?
Enjoy this festive season on LinkedIn!
December 17, 2025 at 8:05 AM
Enjoy this festive season on LinkedIn!
December 4, 2025 at 10:03 AM
Zou dat in Galatasaray zijn gebeurd die stuntzege?
November 25, 2025 at 8:55 PM
Zou dat in Galatasaray zijn gebeurd die stuntzege?
Finding the putative target of a TCR is hard!
But I am really excited to see that innovative cancer therapy companies like Obsidian Therapeutics are getting some real value out of using our database + machine learning algorithm.
But I am really excited to see that innovative cancer therapy companies like Obsidian Therapeutics are getting some real value out of using our database + machine learning algorithm.
November 24, 2025 at 9:26 AM
Finding the putative target of a TCR is hard!
But I am really excited to see that innovative cancer therapy companies like Obsidian Therapeutics are getting some real value out of using our database + machine learning algorithm.
But I am really excited to see that innovative cancer therapy companies like Obsidian Therapeutics are getting some real value out of using our database + machine learning algorithm.
Crazy excited about Jack White being on tour again! He was just announced headlining Best Kept Secret festival in the NL 🥳
October 28, 2025 at 1:47 PM
Crazy excited about Jack White being on tour again! He was just announced headlining Best Kept Secret festival in the NL 🥳
Episode 3 of “The Repertoire Room” has just been released!
After 2 episodes with technology providers in the TCR sequencing space, I now wanted to have a conversation with someone that was really using these technologies to push innovative therapies to patients.
Enter: @armanaksoy.bsky.social
After 2 episodes with technology providers in the TCR sequencing space, I now wanted to have a conversation with someone that was really using these technologies to push innovative therapies to patients.
Enter: @armanaksoy.bsky.social
October 28, 2025 at 12:52 PM
Episode 3 of “The Repertoire Room” has just been released!
After 2 episodes with technology providers in the TCR sequencing space, I now wanted to have a conversation with someone that was really using these technologies to push innovative therapies to patients.
Enter: @armanaksoy.bsky.social
After 2 episodes with technology providers in the TCR sequencing space, I now wanted to have a conversation with someone that was really using these technologies to push innovative therapies to patients.
Enter: @armanaksoy.bsky.social
This might end up in the void, but is ESMO IO worth attending?
October 27, 2025 at 2:39 PM
This might end up in the void, but is ESMO IO worth attending?
If you asked me 10 years ago, I wouldn't have guessed that I would ever give a guest lecture on "Innovation and Entrepreneurship"
Talks about microbiology, sequencing technologies, gene editing technologies, fermentation or bioinformatics: yes. But Entrepreneurship, nah :)
Talks about microbiology, sequencing technologies, gene editing technologies, fermentation or bioinformatics: yes. But Entrepreneurship, nah :)
October 3, 2025 at 9:00 AM
If you asked me 10 years ago, I wouldn't have guessed that I would ever give a guest lecture on "Innovation and Entrepreneurship"
Talks about microbiology, sequencing technologies, gene editing technologies, fermentation or bioinformatics: yes. But Entrepreneurship, nah :)
Talks about microbiology, sequencing technologies, gene editing technologies, fermentation or bioinformatics: yes. But Entrepreneurship, nah :)
Reposted by Sander Wuyts, PhD 🧬
Tonight at a public meeting I clapped when everyone else was murmuring in fear and worry about the idea of reducing the number of lanes on a road in order to accommodate wider sidewalks and bike lanes. Definitely an outlier.
I don’t hate cars. Like most North American males I was raised to think cars are cool, and as a design nerd, few objects are more eye-catching.
I hate surrendering our streets, our cities and our lives to them.
Car dependence isn’t freedom.
Great cartoon by @robcowan.bsky.social #CarDependency
I hate surrendering our streets, our cities and our lives to them.
Car dependence isn’t freedom.
Great cartoon by @robcowan.bsky.social #CarDependency
October 2, 2025 at 3:56 AM
Tonight at a public meeting I clapped when everyone else was murmuring in fear and worry about the idea of reducing the number of lanes on a road in order to accommodate wider sidewalks and bike lanes. Definitely an outlier.
Always curious whether this new update will bring new insights for you!
We committed ourselves to push new TCR-epitope data to our database every quarter.
Last week we published a new version of ImmuneWatch DETECT with TCRs for 75 different epitopes, of which 49 were not yet in our database.
Many new HPV epitopes!
immunewatch.gitlab.io/detect-docs/...
Last week we published a new version of ImmuneWatch DETECT with TCRs for 75 different epitopes, of which 49 were not yet in our database.
Many new HPV epitopes!
immunewatch.gitlab.io/detect-docs/...
September 25, 2025 at 11:48 AM
Always curious whether this new update will bring new insights for you!
Episode 2 of my podcast, the Repertoire Room is live!
In this podcast I hope to have insightful conversations with people working on TCR sequencing and analysis.
Now I sat down with the developer of one of the most used tools in the field: MiXCR
www.immunewatch.com/news/podcast...
In this podcast I hope to have insightful conversations with people working on TCR sequencing and analysis.
Now I sat down with the developer of one of the most used tools in the field: MiXCR
www.immunewatch.com/news/podcast...
Podcast: The Repertoire Room - Episode 2 featuring Stanislav Poslavsky (MiLaboratories)
www.immunewatch.com
September 17, 2025 at 10:46 AM
Episode 2 of my podcast, the Repertoire Room is live!
In this podcast I hope to have insightful conversations with people working on TCR sequencing and analysis.
Now I sat down with the developer of one of the most used tools in the field: MiXCR
www.immunewatch.com/news/podcast...
In this podcast I hope to have insightful conversations with people working on TCR sequencing and analysis.
Now I sat down with the developer of one of the most used tools in the field: MiXCR
www.immunewatch.com/news/podcast...
Never thought I was going to post something like this on our Slack but after submitting some EU-grants it felt like the right thing to do 😂
September 16, 2025 at 12:54 PM
Never thought I was going to post something like this on our Slack but after submitting some EU-grants it felt like the right thing to do 😂
From now on, my reading stats and recaps will be incorrect for eternity.
September 15, 2025 at 8:01 PM
From now on, my reading stats and recaps will be incorrect for eternity.
Reposted by Sander Wuyts, PhD 🧬
We are looking for a postdoc to study single-cell transcriptional heterogeneity in the human skin microbiome.
We have a new protocol mostly developed, but need someone to see it through. Experience with protocol dev or RNAseq appreciated.
Funded by a new grant from MIT-HEALS.
We have a new protocol mostly developed, but need someone to see it through. Experience with protocol dev or RNAseq appreciated.
Funded by a new grant from MIT-HEALS.
September 12, 2025 at 4:49 PM
We are looking for a postdoc to study single-cell transcriptional heterogeneity in the human skin microbiome.
We have a new protocol mostly developed, but need someone to see it through. Experience with protocol dev or RNAseq appreciated.
Funded by a new grant from MIT-HEALS.
We have a new protocol mostly developed, but need someone to see it through. Experience with protocol dev or RNAseq appreciated.
Funded by a new grant from MIT-HEALS.
Reposted by Sander Wuyts, PhD 🧬
Het aantal verkeersdoden in een land en stad is een politieke keuze. Geen technische. Dit is oud nieuws en al heel lang bekend. Doe wat Helsinki en Oslo doen die al jarenlang nul verkeersdoden hebben. Bange politici weigeren de automobilist aan te pakken.
August 5, 2025 at 4:37 AM
Het aantal verkeersdoden in een land en stad is een politieke keuze. Geen technische. Dit is oud nieuws en al heel lang bekend. Doe wat Helsinki en Oslo doen die al jarenlang nul verkeersdoden hebben. Bange politici weigeren de automobilist aan te pakken.
Reposted by Sander Wuyts, PhD 🧬
Recently I learnt that EMBL-EBI has a free online course about AlphaFold — how it works, strengths and limitations, how to use it — and it's very good!
There are also little quizzes and interactives.
www.ebi.ac.uk/training/onl...
There are also little quizzes and interactives.
www.ebi.ac.uk/training/onl...
AlphaFold - A practical guide
AlphaFold - A practical guide
www.ebi.ac.uk
July 21, 2025 at 3:33 PM
Recently I learnt that EMBL-EBI has a free online course about AlphaFold — how it works, strengths and limitations, how to use it — and it's very good!
There are also little quizzes and interactives.
www.ebi.ac.uk/training/onl...
There are also little quizzes and interactives.
www.ebi.ac.uk/training/onl...
Reposted by Sander Wuyts, PhD 🧬
First day of #ATCR25 in Antwerp: done ☑️ 🤩
Picture of Antwerp city station
#immunology #TCRrepertoire #Tcells #research
Picture of Antwerp city station
#immunology #TCRrepertoire #Tcells #research
May 27, 2025 at 4:06 PM
First day of #ATCR25 in Antwerp: done ☑️ 🤩
Picture of Antwerp city station
#immunology #TCRrepertoire #Tcells #research
Picture of Antwerp city station
#immunology #TCRrepertoire #Tcells #research
Reposted by Sander Wuyts, PhD 🧬
#Abstract submission deadline for #ATCR2025 is this Friday!
We are again very grateful to have such a strong lineup of #Tcell-receptor experts joining us in Antwerp. Currently at 80% capacity so do not wait to register.
www.uantwerpen.be/atcr2025
We are again very grateful to have such a strong lineup of #Tcell-receptor experts joining us in Antwerp. Currently at 80% capacity so do not wait to register.
www.uantwerpen.be/atcr2025
April 14, 2025 at 11:52 AM
#Abstract submission deadline for #ATCR2025 is this Friday!
We are again very grateful to have such a strong lineup of #Tcell-receptor experts joining us in Antwerp. Currently at 80% capacity so do not wait to register.
www.uantwerpen.be/atcr2025
We are again very grateful to have such a strong lineup of #Tcell-receptor experts joining us in Antwerp. Currently at 80% capacity so do not wait to register.
www.uantwerpen.be/atcr2025